HOUSTON, TX / ACCESSWIRE / April 4, 2019 / Over the next decade, spending on worldwide cannabis could reach $57 billion by 2027, according to Arcview Market Research and BDS Analytics.
In their report, ''The Road Map to $57 Billion Worldwide Market,'' analysts note that the South American market for example could grow from $125 million in 2018 to $776 million by 2027. They also note that Germany could become the leader in the European cannabis market, with Italy expected to see $1.2 billion cannabis sales by 2027.
Even Australia's legal cannabis market is expected to explode from $52 million in 2018 to more than $1.2 billion by 2017.
In short, the cannabis boom has only just begun.
As the global story begins to take shape, some of top companies to keep an eye on include MYM Nutraceuticals Inc. (CSE:MYM)(OTC:MYMMF),PharmaCielo Ltd. (OTC:PHCEF)(TSXV:PCLO), and OrganiGram Holdings Inc. (TSXV:OGI)(OTC:OGRMF).
MYM Nutraceuticals (MYM)(MYMMF) just updated its 2019 strategic plan. The updated plan can be found at mym.ca, under the ''Investors'' tab. Some of the key highlight include plans for global cultivation, extraction, distribution, and the creation of unique brands.
At the moment, MYM is positioning itself to become a global leader in cannabis, hemp, and seed cultivation through a variety of global partnerships in agricultural friendly zones around the world. By creating multiple partnerships around the world, the company is in a prime position to take advantage of cultivating in low cost regions while distributing in high revenue regions thereby maximizing profits.
In addition, ''Key additions to senior management offer an opportunity to focus the Company's efforts on new projects around the globe,'' said Howard Steinberg, CEO of MYM. ''Our updated plan includes a targeted focus on low-cost cannabis and hemp production sites across the globe while distributing into countries with high revenue potential thereby maximizing profits.''
For More Information on MYM Nutraceuticals, Inc. Click Here.
Analysts at GMP just initiated coverage on PharmaCielo Ltd. (PHCEF)(PCLO) with a Buy rating and a price target of C$12. They also note that PCLO is the best pure-play on the global CBD market. '' We consider PCLO to be the most advanced Colombian licensed producer currently, providing a ~6-18 month first-mover advantage over nearly all Colombian competitors. In addition, with CBD extract capacity expected to reach ~17 tonnes in 2019, we believe this qualifies PCLO as the largest international publicly-traded producer.''
''With favorable Colombian regulations, we estimate PCLO could have CBD yields ~250x-300x higher than those available to global peers. We believe PCLO could achieve CBD extract production costs as low as ~$0.15-0.25/gram, potentially the lowest globally.''
For More Information on PharmaCielo Ltd., Click Here.
OrganiGram Holdings (OGI) is ramping up production to capitalize on new market opportunities as an existing licensed producer. An active expansion includes a 15,000 sq. ft. extract processing facility that could prove quite useful, as the cannabis market progresses.
In recent months, the company just signed a letter of intent with the Société québécoise du cannabis (SQDC). The company now has distribution in place for all ten Canadian provinces.
''Organigram's growth strategy has always focused on establishing a strong national footprint and building our brand presence with the Edison Cannabis line nationally,'' says OGRMF CEO Greg Engel. ''We are proud to work with our partners across the country to help ensure Canadians have access to a reliable supply of premium cannabis products for both medical and adult recreational use. We look forward to continuing to build on these relationships as we look ahead to the legalization of cannabis edibles.''
For More Information on OrganiGram Holdings Inc., Click Here.
Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from aressed or implied by such statements. Winning Media which has a partnership with www.WallStreetNation.com is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release.
For making specific investment decisions, readers should seek their own advice. Winning Media, which has a partnership with www.WallStreetNation.com, is only compensated for its services in the form of cash-based compensation. Pursuant to an agreement between Winning Media (partners of WallStreetNation.com) and MYM Nutraceuticals Inc., Winning Media has been paid four thousand dollars for advertising and marketing services for MYM Nutraceuticals Inc. We own ZERO shares of MYM Nutraceuticals Inc. Please click here for full disclaimer.
View source version on accesswire.com: